![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 18")
GLP-1 Digest: Latest Research and Clinical Updates April 16,
Clinical Takeaway This issue examines a convergence of compelling evidence across metabolic medicine, with new research strengthening the case for GLP-1 receptor agonists in liver disease management, weight loss optimization, and diabetes prevention.…
GLP-1 Receptor Agonist Shows Liver Benefits in New Research
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic NewsObservational StudyMetabolic Liver DiseaseSemaglutideEndocrinologyPreclinical Mouse…
Two compounds found in cannabis plant reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCAging Why This Matters This study identifying specific cannabis compounds that may reverse liver…
Cannabis compounds reverse fatty liver disease in mice – Instagram
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Liver DiseasePreclinical…
Two compounds found in surprising substance reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Liver DiseaseCbdCbgPreclinical…
Two compounds found in cannabis plant reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Liver…
Therapeutic potential of cannabidiol supplementation in mitigating lipid precursors of inflammation in hepatic steatosis progression.
This study investigated the effects of cannabidiol (CBD) on early-stage inflammation, a key factor in the progression of liver diseases from metabolic dysfun...
CBD And CBG From The Cannabis Plant Could Help Treat A Common Liver Condition | IFLScience
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Liver DiseaseCbdCbgPreclinical…
Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.
Metabolic dysfunction-associated fatty liver disease (MAFLD), recently redefined from non-alcoholic fatty liver disease (NAFLD), highlights the central role ...
Aussie Study: Cannabis Reverses Common Disease – indonesiakini
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDLiver DiseaseHealth Benefits I apologize – I need to choose only from your provided list. Here's…